Loading...
•
Sep 30, 2022
Bausch Health Q3 2022 Earnings Report
Bausch Health's third-quarter performance reflected resilience with revenue of $2.046 billion, a decrease of 3% but an organic increase of 2%, driven by growth in key segments and strategic debt reduction.
Key Takeaways
Bausch Health reported a revenue of $2.046 billion for Q3 2022, a 3% decrease compared to Q3 2021, but showed a 2% increase on an organic basis. The company highlighted top-line improvements in several segments and a successful debt exchange offer that reduced debt by $2.5 billion. They have updated full year guidance.
Revenues of $2.046 billion, down 3% reported, up 2% organic basis
Third quarter sales improved sequentially, notably Salix, International, and Solta
Successful debt exchange offer reduces debt by $2.5 billion
Company updates full year guidance
Revenue by Segment
Forward Guidance
Bausch Health updated its consolidated guidance for the full year 2022 as follows: •Full year revenue range of $8.0 - $8.17 billion compared with prior guidance of $8.05 - $8.22 billion •Full year revenues flat to up 2% on an organic basis (unchanged) •Full year Adjusted EBITDA (non-GAAP)1 range of $2.99 - $3.09 billion compared with prior guidance of $3.02 - $3.12 billion
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...